Researchers from the Columbia University Department of Neurology discovered a genetic variant that may reduce the odds of developing Alzheimer’s disease by up to 70%.
Yian Gu, MD, MS, PhD, Associate Professor of Neurological Sciences at CUMC, commented on a new study that examined the link between healthy diet and reduced risk of developing dementia.
James Noble, MD, MS, Associate Professor of Neurology in the Taub Institute and the Sergievsky Center at CUMC discusses his diverse body of work and the motivation behind his passion projects.
Caghan Kizil, PhD, MSc, Associate Professor of Neurological Sciences in Neurology and in the Taub Institute, talks about using zebrafish as a model organism in his research.
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.